Gavin Newsom Sues Fox News for $787 Million over Defamatory Coverage
California Governor Gavin Newsom sues Fox News for defamation, demands $787 million over false coverage of a call with President Trump.
Yearly Archives
2025
Supreme Court Upholds Structure of Preventive Health Task Force Under ACA
Supreme Court upholds structure of health task force recommending preventive services covered by the Affordable…
White House Donates New Trump Portrait to Hang in Colorado State Capitol
The White House has donated a new portrait of President Trump to replace the "purposefully distorted" one in…
Senate Vote on Bill Causes Damage to Renewables Industry
Senate to vote on omnibus bill affecting renewable energy tax credits. Details remain uncertain, potentially limiting small developers.
Smooth Transition: Newborns Gift Older Siblings
Introducing New Siblings: How to Navigate Toddler Jealousy
When it comes to sibling dynamics, the arrival of a new…
Beat Summer Heat with a Personal Trainer: Your Ultimate Fitness Solution
Benefits of Engaging a Personal Trainer
Undoubtedly, professional personal training offers a unique approach to…
Trump Halts US-Canada Trade Talks Over Digital Services Tax – CNBC
TL/DR -
Former President Donald Trump ended all U.S. trade talks with Canada due to a digital services tax. Trump threatened to impose higher tariffs following this decision. Despite the G-7 agreement, Canada's digital services tax continues to remain in place.
Trump Halts U.S. Trade Talks with Canada Due to Digital Services Tax
Trump…
Understanding the Impact of Tariffs on Your Wallet and How to Prepare
Understanding tariffs: Taxes on imported goods may impact your wallet, but don't panic. Learn about their meaning,…
Scott Updates Banking Provisions in One Big Beautiful Bill
Senate Republicans release updated legislative text of One Big Beautiful Bill, aimed at reducing waste in federal…
Study Reveals Persistent Burden of Antimicrobial-Resistant Pathogens in the US
Despite a decline in AMR-related hospital admissions from 2012 to 2022, the burden of antimicrobial resistance remains high in the US.